Entity Details

Primary name GTR1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP11166
EntryNameGTR1_HUMAN
FullNameSolute carrier family 2, facilitated glucose transporter member 1
TaxID9606
Evidenceevidence at protein level
Length492
SequenceStatuscomplete
DateCreated1989-07-01
DateModified2021-06-02

Ontological Relatives

GenesSLC2A1

GO terms

Show/Hide Table
GOName
GO:0000139 Golgi membrane
GO:0001666 response to hypoxia
GO:0001917 photoreceptor inner segment
GO:0001939 female pronucleus
GO:0005324 long-chain fatty acid transporter activity
GO:0005355 glucose transmembrane transporter activity
GO:0005829 cytosol
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0005901 caveola
GO:0005989 lactose biosynthetic process
GO:0007417 central nervous system development
GO:0007565 female pregnancy
GO:0010827 regulation of glucose transmembrane transport
GO:0014704 intercalated disc
GO:0015911 long-chain fatty acid import across plasma membrane
GO:0016020 membrane
GO:0016323 basolateral plasma membrane
GO:0016324 apical plasma membrane
GO:0019852 L-ascorbic acid metabolic process
GO:0019900 kinase binding
GO:0021987 cerebral cortex development
GO:0030018 Z disc
GO:0030496 midbody
GO:0030864 cortical actin cytoskeleton
GO:0032868 response to insulin
GO:0033300 dehydroascorbic acid transmembrane transporter activity
GO:0042149 cellular response to glucose starvation
GO:0042383 sarcolemma
GO:0042470 melanosome
GO:0042802 identical protein binding
GO:0042910 xenobiotic transmembrane transporter activity
GO:0043621 protein self-association
GO:0045494 photoreceptor cell maintenance
GO:0050796 regulation of insulin secretion
GO:0055056 D-glucose transmembrane transporter activity
GO:0065003 protein-containing complex assembly
GO:0070062 extracellular exosome
GO:0071260 cellular response to mechanical stimulus
GO:0071474 cellular hyperosmotic response
GO:0072562 blood microparticle
GO:0098708 glucose import across plasma membrane
GO:0098793 presynapse
GO:0150104 transport across blood-brain barrier
GO:1904016 response to Thyroglobulin triiodothyronine
GO:1904659 glucose transmembrane transport

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane
Melanosome
Photoreceptor inner segment

Domains

Show/Hide Table
DomainNameCategoryType
IPR002439 Glucose transporter, type 1 (GLUT1)FamilyFamily
IPR003663 Sugar/inositol transporterFamilyFamily
IPR005828 Major facilitator, sugar transporter-likeFamilyFamily
IPR005829 Sugar transporter, conserved siteSiteConserved site
IPR020846 Major facilitator superfamily domainDomainDomain
IPR036259 MFS transporter superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
606777 OMIMGLUT1 deficiency syndrome 1 (GLUT1DS1)A neurologic disorder showing wide phenotypic variability. The most severe 'classic' phenotype comprises infantile-onset epileptic encephalopathy associated with delayed development, acquired microcephaly, motor incoordination, and spasticity. Onset of seizures, usually characterized by apneic episodes, staring spells, and episodic eye movements, occurs within the first 4 months of life. Other paroxysmal findings include intermittent ataxia, confusion, lethargy, sleep disturbance, and headache. Varying degrees of cognitive impairment can occur, ranging from learning disabilities to severe mental retardation. The disease is caused by variants affecting the gene represented in this entry.
612126 OMIMGLUT1 deficiency syndrome 2 (GLUT1DS2)A clinically variable disorder characterized primarily by onset in childhood of paroxysmal exercise-induced dyskinesia. The dyskinesia involves transient abnormal involuntary movements, such as dystonia and choreoathetosis, induced by exercise or exertion, and affecting the exercised limbs. Some patients may also have epilepsy, most commonly childhood absence epilepsy. Mild mental retardation may also occur. In some patients involuntary exertion-induced dystonic, choreoathetotic, and ballistic movements may be associated with macrocytic hemolytic anemia. The disease is caused by variants affecting the gene represented in this entry.
608885 OMIMStomatin-deficient cryohydrocytosis with neurologic defects (SDCHCN)A rare form of stomatocytosis characterized by episodic hemolytic anemia, cold-induced red cells cation leak, erratic hyperkalemia, neonatal hyperbilirubinemia, hepatosplenomegaly, cataracts, seizures, mental retardation, and movement disorder. The disease is caused by variants affecting the gene represented in this entry.
601042 OMIMDystonia 9 (DYT9)An autosomal dominant neurologic disorder characterized by childhood onset of paroxysmal choreoathetosis and progressive spastic paraplegia. Most patients show some degree of cognitive impairment. Other variable features may include seizures, migraine headaches, and ataxia. The disease is caused by variants affecting the gene represented in this entry.
614847 OMIMEpilepsy, idiopathic generalized 12 (EIG12)A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. Seizure types include juvenile myoclonic seizures, absence seizures, and generalized tonic-clonic seizures. In some EIG12 patients seizures may remit with age. Disease susceptibility is associated with variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00126 Ascorbic acidDrugbanksmall molecule
DB00237 ButabarbitalDrugbanksmall molecule
DB00292 EtomidateDrugbanksmall molecule
DB01914 D-glucoseSwissprotsmall molecule
DB02709 ResveratrolDrugbanksmall molecule
DB08830 Dehydroascorbic acidSwissprotsmall molecule
DB08831 2-deoxyglucoseSwissprotsmall molecule
DB09341 Dextrose, unspecified formSwissprotsmall molecule
DB09502 Fludeoxyglucose (18F)Swissprotsmall molecule
DB11059 CarboxymethylcelluloseDrugbanksmall molecule